Recent News

KEYNOTE-629: Pembrolizumab in Metastatic Cutaneous Squamous Cell Carcinoma

Front-Line Immunotherapy for Locally Advanced Basal Cell Carcinoma: Case Studies

Sex-Dependent Distribution of Non-Melanoma Skin Cancers of the Pinna

Sun Health Behaviors and Skin Cancer Risk in Children: Public Health Report From Ireland

Case Study Features Association Between Rare Skin Condition and Basal Cell Carcinoma

Identifying High-Risk Patients With Cutaneous Squamous Cell Carcinoma for Clinical Trial

Health-Related Quality of Life With Cemiplimab for Skin Cancer

Call to Action: Skin Cancer Surveillance in Patients With Organ Transplants

AACR II: Linking HPV Infection to Skin Cancer in Patients With CLL

Immune-Mediated Adverse Events With Concomitant Radiotherapy and Immunotherapy

AACR II: Does Cyclooxygenase-2 Inhibitor Use Reduce the Risk of Skin Cancer?

AACR II: Early Tanning Bed Use and Risk for Skin Cancer

Pembrolizumab Approved by FDA for Cutaneous Squamous Cell Carcinoma

AACR II: Do Permanent Hair Dyes Increase the Risk of Skin Cancer?

ASCO20: Upfront Treatment With Cemiplimab for Locally Advanced Skin Cancer

Preclinical Study of Plant Flavonoid in Treatment of Squamous Cell Skin Cancer

ASCO20: Longer-Term Follow-Up Supports Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma

ASCO20: Predicting Subclinical Progression of Squamous Cell Carcinoma

ASCO20: Total-Body Skin Exams and Diagnosis of Skin Cancers

ASCO20: Targeting MDM2 in Merkel Cell Carcinoma

ASCO20: Preserving Eye Function in Locally Advanced Orbital/Periocular Basal Cell Carcinoma

Skin Cancer Awareness Month: Recommendations for Prevention

Managing Patients With Skin Cancer During the COVID-19 Pandemic

Exploring Staph Bacteria’s Connection to Growth of Skin Cancers

DDW 2020: Risk of Skin Cancer in Patients With Inflammatory Bowel Disease

COVID-19 and Skin Cancer: Meeting Clinical Challenges in Dermatology

Non-Melanoma Skin Cancer: A Continual Problem for Outdoor Workers

STAT3 Pathway: Therapeutic Target in Cutaneous Squamous Cell Carcinoma?

Pembrolizumab Receives FDA Accelerated Approval for Alternative Dosing Schedule

Does Narrowband UV-B Therapy Increase Risk for Non-Melanoma Skin Cancer?

Moffitt Researchers Identify Tumor Suppressors in Cutaneous Squamous Cell Carcinoma

Could Artificial Intelligence Be the Future for Skin Cancer Screening?

Is Pembrolizumab Active in Treatment of Advanced Skin Cancer?

Electrochemotherapy With Reduced-Dose Bleomycin in Elderly Patients With Skin Cancer

Superficial Radiation Therapy and Non-Melanoma Skin Cancer

Molecular Role of Cox-2 in Cutaneous Squamous Cell Carcinoma

Association Between Mercury Exposure and Non-Melanoma Skin Cancer

Nonsurgical Treatment for Invasive Cutaneous Squamous Cell Carcinoma: A Case Study

Researchers Identify New Genomic Areas Potentially Linked to Increased Skin Cancer Risk

Rates of Skin Cancer Among Sexual Minorities

GW Cancer Center: Site of Clinical Trial of Cemiplimab in High-Risk Skin Cancer